AAV2-R100 Serotype

AAV2 variant engineered for enhanced CNS penetration through rational capsid modification with improved neuronal transduction.

Length: 1 bp

Tropism: CNS (neurons), reduced glial transduction

Characteristics

Single amino acid substitutions improve neuronal specificity. Reduced glial tropism compared to wild-type AAV2. Enhanced CNS penetration following systemic administration.

Applications

Neurological disorders requiring neuron-specific gene delivery. Preclinical CNS gene therapy research.

Literature References

  1. Qiao et al. (2017). Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Mol Ther - Qiao 2017 AAV2 Variants